Stay updated with breaking news from Aileen Wang. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The eight month-long clinical trials on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will likely be conducted by “fourth week of June”, the Department of Science and Technology (DOST) said Saturday, May 29. (Manila Bulletin File Photo) Based on the report of the Phil
The government has allocated P22 million for the conduct of eight month-long clinical trials on the use of Ivermectin as a treatment for coronavirus disease (COVID-19), which will begin in June this year in the country, the Department of Science and Technology (DOST) said late Wednesday night, May 5
Published May 3, 2021, 12:22 PM The Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) said on Monday, May 3, that the clinical trial on the use of Ivermectin as a treatment for coronavirus disease (COVID-19) will involve patients with “non-severe” or those with mild to moderate cases. DOST-PCHRD Executive Director Dr. Jaime C. Montoya (Manila Bulletin File Photo) DOST-PCHRD Executive Director Dr. Jaime C. Montoya said the research team from the University of the Philippines (UP) Manila- Philippine General Hospital (PGH), headed by Dr...
Published May 3, 2021, 1:13 PM The clinical trial results on the use of anti-parasitic drug Ivermectin as a treatment for coronavirus disease (COVID-19) could be expected by January 2022 or by first quarter of 2022, a top official of the Department of Science and Technology-Philippine Council for Health Research and Development (DOST-PCHRD) said Monday, May 3. (Manila Bulletin File Photo) DOST-PCHRD Executive Director Dr. Jaime C. Montoya said preparations were underway to ensure the smooth conduct of the clinical trial, which will likely be conducted by end of May or first week of June. DOS...
By JULIA MARI ORNEDO, GMA News Published April 29, 2021 1:48pm The local clinical trial for the use of antiparasitic drug ivermectin on COVID-19 patients is seen to start at the end of May or in early June, an official from the Department of Science and Technology (DOST) said Thursday. Executive director Jaime Montoya of the DOST-Philippine Council for Health Research and Development said the trial will run for about six months, with Metro Manila being eyed as the venue for ease of patient recruitment. Around 1,200 patients are expected to participate, Montoya said, adding the trial wi...